Viewing Study NCT01902251


Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2026-04-11 @ 6:23 PM
Study NCT ID: NCT01902251
Status: COMPLETED
Last Update Posted: 2014-09-09
First Post: 2013-07-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patients
Sponsor: Astellas Pharma Europe B.V.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module